Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II extension study of polyethylene glycol recombinant human growth hormone injection for idiopathic short stature in children
CTR20160707Phase 2Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jan 2017; status: active.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20160707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160707.